Options for the “No-Option” Patient: Evaluation / Treatment of Refractory Angina

Options for the “No-Option” Patient: Evaluation / Treatment of Refractory Angina

By Scottsdale Interventional Forum 2024 FEATURING Timothy Henry

617 views

May 9, 2024

Comments 0

ANOCA, Coronary Artery Spasm, and PFO

Controversies in Interventional Cardiovascular Therapies - CICT 2024

J. Tobis

95 views

AHA 2022: Diagnosing Ischemia and Non Obstructive Coronary Artery Di…

AHA 2022 Conference Coverage

J. Sweeny

3.7K views

Cardiac PET Explains Angina: Physiologic Motifs and Mechanisms

Yale School of Medicine

N. Johnson

146 views

Coronary Microvascular Disease in HFpEF: Pathophysiology, Diagnosis …

MUSC Cardiology

S. Mohammed

110 views

ISCHEMIA Trial: How Prevalent Are Non-obstructive Coronary Artery Di…

American College of Cardiology

D. Adams, V. Fuster, R. Mehran, A. Lala-Trindade, V. Reddy

2.3K views

TCT 2022: Angina - The Scope of the Problem

TCT 2022 Conference Coverage

T. Henry

656 views

ACC 2024 Insights: Evaluating and Treating Coronary Microvascular Di…

ACC 2024 Insights

T. Henry

1.5K views

The Coronary Sinus Reducer for Refractory Angina: COSIRA-II Trial

Scottsdale Interventional Forum 2023

T. Henry

94 views

Treatment for the “No Option” Refractory Angina Patient

Scottsdale Interventional Forum 2022

T. Henry

1.3K views

Follow the Evidence from the ISCHEMIA Trial: Should You Try Medical …

Complex Interventional Cardiovascular Therapy (CICT) 2021

R. Gulati

1.2K views

ACC 2023: Other Interventional Solutions for Refractory Angina

ACC 2023 Conference Coverage

T. Henry

572 views

Results of the NOBLE Trial: Is CABG Preferable to PCI?

Complex Interventional Cardiovascular Therapy (CICT) 2021

S. Bailey

1.2K views